Remove 2021 Remove Documentation Remove Omnicell
article thumbnail

Omnicell and Fresenius Kabi Join Forces to Improve Controlled Substance Management

Omnicell

Through a new collaboration between Omnicell and Fresenius Kabi, a global healthcare company focusing on infusion, transfusion, and clinical nutrition, health systems now have new options to manage controlled substances better, reduce diversion, and save nursing time.

article thumbnail

Filings buzz in pharmaceuticals: 65% increase in cloud computing mentions in Q1 of 2022

Pharmaceutical Technology

Mentions of cloud computing within the filings of companies in the pharmaceutical industry rose 65% between the final quarter of 2021 and the first quarter of 2022. Of the 10 biggest employers in the pharmaceutical industry, IQVIA was the company which referred to cloud computing the most between April 2021 and March 2022.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Filings buzz in pharmaceuticals: 22% decrease in robotics mentions in Q1 of 2022

Pharmaceutical Technology

Mentions of robotics within the filings of companies in the pharmaceutical industry fell 22% between the final quarter of 2021 and the first quarter of 2022. Of the 10 biggest employers in the pharmaceutical industry, J&J was the company which referred to robotics the most between April 2021 and March 2022. of all sentences.

article thumbnail

Why You Need Pharmacy Automation in Your OR

Omnicell

Mary Selzo, RPh Practicing Pharmacist and Senior Clinical Product Manager, Omnicell Automated dispensing cabinets are the backbone of most medication distribution systems, with 95% adoption in nursing units across the U.S. Ideally pharmacy and anesthesia providers should work in partnership to maintain controlled substance accountability.

article thumbnail

In the Face of Resistance, 340B Coalition Summer Conference Proves Program’s Worth

Omnicell

in 2021, reaching $93.6 During an Omnicell-hosted View from Capitol Hill Luncheon and Panel Discussion , Cathy White, 340B Pharmacy Financial Analyst at Cone Health, explained how manufacturer restrictions have impacted her organization. Omnicell can be a valued partner in this effort.